Literature DB >> 24338959

Compliance with joint commission measures in state-designated stroke centers.

Spozhmy Panezai1, Tefera Gezmu, Jawad Kirmani, Florence Chukwuneke, Ratna Bitra, Abate Mammo, Martin Gizzi.   

Abstract

BACKGROUND: Comparison of state-designated primary and comprehensive stroke centers (PSCs and CSCs) with regard to adherence to nationally accepted performance standards are scarce. The objective of this study was to examine if a significant association exists between level of designation and fulfillment of Joint Commission (JC) stroke core measures.
METHODS: A retrospective comparative data analysis of the New Jersey acute stroke registry for the calendar years 2010 and 2011 was performed. JC core measures were compared by hospital level (PSCs vs CSCs). Adjusted odds ratios (aOR) were estimated for association between hospital levels and fulfillment of JC core measures. Median door-to-thrombolytic time was also compared.
RESULTS: There were 36,892 acute stroke admissions. PSCs had 60% of the patients, whereas CSCs had 40%. Hemorrhagic stroke admissions were about 2 times more frequent at CSCs than PSCs (13.3% and 7.1%, respectively). CSCs adhered better to 6 of the 8 JC measures than PSCs. Of eligible patients, 19.5% received thrombolytic therapy at CSCs compared to 9.6% at PSCs, with a 44% difference in provision of thrombolytic therapy (aOR = 0.28, 95% confidence interval: 0.24-0.34). Median door-to-thrombolytic drug times was 65 minutes at CSCs compared to 74.0 minutes at PSCs (P < 0.0001).
CONCLUSIONS: New Jersey state-designated CSCs are better at adhering to the JC core stroke measures and have shorter door-to-thrombolytic drug times.
© 2013 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 24338959     DOI: 10.1002/jhm.2133

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  4 in total

Review 1.  Effectiveness of regionalized systems for stroke and myocardial infarction.

Authors:  James P Rhudy; Marie A Bakitas; Kristiina Hyrkäs; Rita A Jablonski-Jaudon; Erica R Pryor; Henry E Wang; Anne W Alexandrov
Journal:  Brain Behav       Date:  2015-09-23       Impact factor: 2.708

2.  Endovascular Stroke Therapy Results Improve over Time: The 'Learning Curve' at a New Comprehensive Stoke Center.

Authors:  Ethan A Benardete; Anil K Nair
Journal:  Cerebrovasc Dis Extra       Date:  2015-01-07

3.  Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers.

Authors:  Gregory Imbarrato; Joshua Bentley; Ajeet Gordhan
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun

4.  Geographic Analysis of Mobile Stroke Unit Treatment in a Dense Urban Area: The New York City METRONOME Registry.

Authors:  Benjamin R Kummer; Mackenzie P Lerario; Madeleine D Hunter; Xian Wu; Elizabeth S Efraim; Setareh Salehi Omran; Monica L Chen; Ivan L Diaz; Daniel Sacchetti; Tim Lekic; Erin R Kulick; Sammy Pishanidar; Saad A Mir; Yi Zhang; Glenn Asaeda; Babak B Navi; Randolph S Marshall; Matthew E Fink
Journal:  J Am Heart Assoc       Date:  2019-12-04       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.